{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:57:56Z","timestamp":1781323076762,"version":"3.54.1"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7351-26","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:09:40Z","timestamp":1781129380000},"source":"Crossref","is-referenced-by-count":0,"title":["&lt;i&gt;Mycobacterium brisbanense&lt;\/i&gt; Pulmonary Disease Treated with a Macrolide-Based Multidrug Regimen: A Case Report"],"prefix":"10.2169","author":[{"given":"Yuki","family":"Nakaya","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoharu","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutiara","family":"Fatimah","sequence":"additional","affiliation":[{"name":"Department of Infection Metagenomics, Research Institute for Microbial Diseases, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Infection Metagenomics, Research Institute for Microbial Diseases, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Funauchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tsukaguchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijiro","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Iwahashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Tone","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Shiroyama","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Infection Metagenomics, Research Institute for Microbial Diseases, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kumanogoh","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Maleki MR, Moaddab SR. The growing impact of nontuberculous mycobacteria: A multidisciplinary review of ecology, pathogenesis, diagnosis, and treatment. Infect Med (Beijing) 4: 100203, 2025.","DOI":"10.1016\/j.imj.2025.100203"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Clin Infect Dis 71: e1-e36, 2020.","DOI":"10.1093\/cid\/ciaa241"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kim SY, Moon SM, Jhun BW, et al. Species distribution and macrolide susceptibility of <i>Mycobacterium fortuitum<\/i> complex clinical isolates. Antimicrob Agents Chemother 63: e02331-18, 2019.","DOI":"10.1128\/AAC.02331-18"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Schinsky MF, Morey RE, Steigerwalt AG, et al. Taxonomic variation in the <i>Mycobacterium fortuitum<\/i> third biovariant complex: description of <i>Mycobacterium boenickei<\/i> sp. nov., <i>Mycobacterium houstonense<\/i> sp. nov., <i>Mycobacterium neworleansense<\/i> sp. nov. and <i>Mycobacterium brisbanense<\/i> sp. nov. and recognition of <i>Mycobacterium porcinum<\/i> from human clinical isolates. Int J Syst Evol Microbiol 54: 1653-1667, 2004.","DOI":"10.1099\/ijs.0.02743-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Poh ME, Liam CK, Ng KP, Tan R. <i>Mycobacterium brisbanense<\/i> species nova isolated from a patient with chronic cavitary lung infection. Chest 145: 858-860, 2014.","DOI":"10.1378\/chest.13-1952"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Gynthersen R, Qvist T, Andersen \u00c5B, Katzenstein TL. <i>Mycobacterium brisbanense<\/i> lung infection facilitated by steroid induced adrenal insufficiency. APMIS 127: 106-108, 2019.","DOI":"10.1111\/apm.12911"},{"key":"7","unstructured":"7. Woods GL, Brown-Elliott BA, Conville PS, et al. CLSI Standards: Guidelines for Health Care Excellence. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes. Clinical and Laboratory Standards Institute, Wayne (PA),."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416, 2007.","DOI":"10.1164\/rccm.200604-571ST"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Park S, Suh GY, Chung MP, et al. Clinical significance of <i>Mycobacterium fortuitum<\/i> isolated from respiratory specimens. Respir Med 102: 437-442, 2008.","DOI":"10.1016\/j.rmed.2007.10.005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Neuschlova M, Vladarova M, Kompanikova J, Sadlonova V, Novakova E. Identification of <i>Mycobacterium<\/i> species by MALDI-TOF mass spectrometry. Adv Exp Med Biol 1021: 37-42, 2017.","DOI":"10.1007\/5584_2017_26"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fukushima K, Matsumoto Y, Matsuki T, et al. MGIT-seq for the identification of nontuberculous mycobacteria and drug resistance: a prospective study. J Clin Microbiol 61: e0162622, 2023.","DOI":"10.1128\/jcm.01626-22"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wee WY, Tan TK, Jakubovics NS, Choo SW. Whole-genome sequencing and comparative analysis of <i>Mycobacterium brisbanense<\/i> reveals a possible soil origin and capability in fertiliser synthesis. PLoS One 11: e0152682, 2016.","DOI":"10.1371\/journal.pone.0152682"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Soria-Herrera RJ, Hern\u00e1ndez-Ram\u00f3n JK, \u00c1lvarez-P\u00e9rez ME, et al. Microbiological quality and presence of clinically relevant nontuberculous mycobacteria in purified water from vending machines in Michoacan, Mexico. Pathogens 14: 886, 2025.","DOI":"10.3390\/pathogens14090886"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Brown-Elliott BA, Nash KA, Wallace RJ Jr. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev 25: 545-582, 2012.","DOI":"10.1128\/CMR.05030-11"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost 7: 911-918, 2009.","DOI":"10.1111\/j.1538-7836.2009.03360.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sim DW, Yu JE, Jeong J, Koh YI. Ciprofloxacin-induced immune-mediated thrombocytopenia: no cross-reactivity with gemifloxacin. J Clin Pharm Ther 43: 134-136, 2018.","DOI":"10.1111\/jcpt.12596"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Coker TJ. Drug-induced immune thrombocytopenia due to moxifloxacin. BMJ Case Rep 2013: bcr2012007501, 2013.","DOI":"10.1136\/bcr-2012-007501"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lee SY, Shunmugarajoo H, Raghunandanan S, Kaur J, Kaur G. Chronic hip arthritis secondary to <i>Mycobacterium brisbanense<\/i> in an immunocompetent pediatric patient: A case report. ACR Open Rheumatol 7: e70136, 2025.","DOI":"10.1002\/acr2.70136"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Pang H, Li G, Wan L, et al. In vitro drug susceptibility of 40 international reference rapidly growing mycobacteria to 20 antimicrobial agents. Int J Clin Exp Med 8: 15423-15431, 2015.","DOI":"10.1155\/2015\/419392"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Campos CED, Vasconcelos RDSS, da Silva WMV, et al. First isolation of <i>Mycobacterium brisbanense<\/i> from humans in the Americas. Mem Inst Oswaldo Cruz 120: e250063, 2025.","DOI":"10.1590\/0074-02760250063"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7351-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:48:57Z","timestamp":1781322537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7351-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7351-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7351-26"}}